D.A. Davidson & CO. Has $20.33 Million Stock Holdings in Medtronic PLC $MDT

D.A. Davidson & CO. trimmed its holdings in Medtronic PLC (NYSE:MDT) by 9.9% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 213,482 shares of the medical technology company’s stock after selling 23,382 shares during the quarter. D.A. Davidson & CO.’s holdings in Medtronic were worth $20,332,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. Brighton Jones LLC raised its stake in shares of Medtronic by 1,368.0% in the fourth quarter. Brighton Jones LLC now owns 39,989 shares of the medical technology company’s stock worth $3,194,000 after acquiring an additional 37,265 shares during the last quarter. Integrated Wealth Concepts LLC increased its holdings in shares of Medtronic by 23.3% in the first quarter. Integrated Wealth Concepts LLC now owns 52,162 shares of the medical technology company’s stock valued at $4,687,000 after purchasing an additional 9,868 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Medtronic by 6.1% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 241,630 shares of the medical technology company’s stock worth $21,695,000 after purchasing an additional 13,973 shares during the last quarter. Petrus Trust Company LTA acquired a new position in Medtronic during the 1st quarter worth $292,000. Finally, Teza Capital Management LLC acquired a new position in Medtronic during the 1st quarter worth $722,000. Institutional investors own 82.06% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the company. Barclays lifted their target price on Medtronic from $109.00 to $111.00 and gave the company an “overweight” rating in a research note on Thursday, November 20th. JPMorgan Chase & Co. boosted their price objective on Medtronic from $90.00 to $100.00 and gave the stock a “neutral” rating in a report on Thursday, November 13th. Robert W. Baird set a $103.00 target price on shares of Medtronic in a research report on Tuesday, December 16th. UBS Group raised their price objective on shares of Medtronic from $95.00 to $102.00 and gave the company a “neutral” rating in a research note on Wednesday, November 19th. Finally, Wall Street Zen cut shares of Medtronic from a “buy” rating to a “hold” rating in a research report on Saturday. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and twelve have given a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $109.94.

Medtronic Stock Down 0.0%

Medtronic stock opened at $96.03 on Monday. The firm has a market capitalization of $123.11 billion, a price-to-earnings ratio of 25.88, a PEG ratio of 2.53 and a beta of 0.71. The company’s 50 day simple moving average is $97.65 and its 200 day simple moving average is $94.13. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.42 and a quick ratio of 1.80. Medtronic PLC has a fifty-two week low of $79.55 and a fifty-two week high of $106.33.

Medtronic (NYSE:MDT) last posted its earnings results on Tuesday, November 18th. The medical technology company reported $1.36 earnings per share for the quarter, topping the consensus estimate of $1.31 by $0.05. The company had revenue of $8.96 billion for the quarter, compared to analyst estimates of $8.86 billion. Medtronic had a net margin of 13.71% and a return on equity of 14.86%. The business’s revenue for the quarter was up 6.6% compared to the same quarter last year. During the same period last year, the business posted $1.26 earnings per share. Medtronic has set its FY 2026 guidance at 5.620-5.660 EPS. As a group, sell-side analysts anticipate that Medtronic PLC will post 5.46 EPS for the current year.

Medtronic Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 16th. Shareholders of record on Friday, December 26th will be issued a dividend of $0.71 per share. The ex-dividend date is Friday, December 26th. This represents a $2.84 annualized dividend and a yield of 3.0%. Medtronic’s payout ratio is currently 76.55%.

About Medtronic

Medtronic plc is a global medical technology company that develops and manufactures a broad range of therapeutic devices and health care solutions. Headquartered legally in Ireland with principal operational offices in the United States, the company markets products to hospitals, physicians and health systems worldwide and has grown from its founding in 1949 into one of the largest medical-device manufacturers serving global health-care markets.

Medtronic’s offerings span several clinical areas, including cardiac rhythm and heart failure (pacemakers, implantable cardioverter‑defibrillators and related cardiac therapies), minimally invasive and surgical technologies (laparoscopic and advanced energy devices, visualization systems and surgical innovations), restorative therapies (spine and orthopedics, neuromodulation and neurovascular treatments) and diabetes management (insulin-delivery systems and glucose monitoring solutions).